JP2024532867A - 被膜拘縮、及び移植体の周囲又は移植体上での線維増殖の阻害に関連する状態の処置のためのフカン及び修飾フカン組成物 - Google Patents

被膜拘縮、及び移植体の周囲又は移植体上での線維増殖の阻害に関連する状態の処置のためのフカン及び修飾フカン組成物 Download PDF

Info

Publication number
JP2024532867A
JP2024532867A JP2024510504A JP2024510504A JP2024532867A JP 2024532867 A JP2024532867 A JP 2024532867A JP 2024510504 A JP2024510504 A JP 2024510504A JP 2024510504 A JP2024510504 A JP 2024510504A JP 2024532867 A JP2024532867 A JP 2024532867A
Authority
JP
Japan
Prior art keywords
medically acceptable
implant
composition
therapeutically effective
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024510504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532867A5 (https=
Inventor
ソン、ヘソン
ミレット、イアン
マイケル ケヴィン スプリンゲート、クリストファー
Original Assignee
エーアールシー メディカル インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エーアールシー メディカル インコーポレイテッド filed Critical エーアールシー メディカル インコーポレイテッド
Publication of JP2024532867A publication Critical patent/JP2024532867A/ja
Publication of JP2024532867A5 publication Critical patent/JP2024532867A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
JP2024510504A 2021-08-20 2022-08-18 被膜拘縮、及び移植体の周囲又は移植体上での線維増殖の阻害に関連する状態の処置のためのフカン及び修飾フカン組成物 Pending JP2024532867A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163235316P 2021-08-20 2021-08-20
US63/235,316 2021-08-20
US202263354322P 2022-06-22 2022-06-22
US63/354,322 2022-06-22
PCT/CA2022/051254 WO2023019360A1 (en) 2021-08-20 2022-08-18 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Publications (2)

Publication Number Publication Date
JP2024532867A true JP2024532867A (ja) 2024-09-10
JP2024532867A5 JP2024532867A5 (https=) 2025-08-25

Family

ID=85239322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024510504A Pending JP2024532867A (ja) 2021-08-20 2022-08-18 被膜拘縮、及び移植体の周囲又は移植体上での線維増殖の阻害に関連する状態の処置のためのフカン及び修飾フカン組成物

Country Status (10)

Country Link
US (1) US20240350531A1 (https=)
EP (1) EP4387630A4 (https=)
JP (1) JP2024532867A (https=)
KR (1) KR20240087708A (https=)
AU (1) AU2022328865A1 (https=)
CA (1) CA3229366A1 (https=)
IL (1) IL310940A (https=)
MX (1) MX2024002190A (https=)
WO (1) WO2023019360A1 (https=)
ZA (1) ZA202401941B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024104757B4 (de) * 2024-02-21 2026-03-26 Acandis Gmbh Medizinische Vorrichtung mit verbesserter antithrombotischer Wirkung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933290B2 (en) * 2007-06-26 2015-01-13 Sofradim Production Sas Mesh implant
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
US11446326B2 (en) * 2018-07-27 2022-09-20 ARC Medical Devices Highly sulfated fucans for the treatment of fibrous adhesions

Also Published As

Publication number Publication date
MX2024002190A (es) 2024-06-24
WO2023019360A1 (en) 2023-02-23
US20240350531A1 (en) 2024-10-24
EP4387630A4 (en) 2025-07-30
ZA202401941B (en) 2025-06-25
IL310940A (en) 2024-04-01
EP4387630A1 (en) 2024-06-26
KR20240087708A (ko) 2024-06-19
AU2022328865A1 (en) 2024-03-14
CA3229366A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
EP2121048B1 (en) Hemostatic compositions and therapeutic regimens
KR20010102231A (ko) 히알루론산 겔 조성물과 그의 제조방법 및 그것을함유하는 의용 재료
JP2018198954A (ja) 改良医療デバイス
KR20150111372A (ko) 주사 시술용 보형물
US9795630B2 (en) Compositions and methods for inducing or enhancing connective tissue repair
Salehi et al. Chitosan/alginate hydrogel adorned with nanoemulsions for potential wound healing: Fabrication, characterization, and biocompatibility evaluation
JP2024532867A (ja) 被膜拘縮、及び移植体の周囲又は移植体上での線維増殖の阻害に関連する状態の処置のためのフカン及び修飾フカン組成物
CN118302175A (zh) 用于治疗与包膜挛缩相关的病症和抑制在移植物周围或移植物上的纤维生长的岩藻聚糖和改性岩藻聚糖组合物
HK40106155A (zh) 用於治疗与包膜挛缩相关的病症和抑制在移植物周围或移植物上的纤维生长的岩藻聚糖和改性岩藻聚糖组合物
KR102939560B1 (ko) 생체적합성 고분자와 하이드록시에틸전분을 함유한 파우더형 유착방지제 및 이의 제조방법
AU2015264846B2 (en) Hemostatic compositions and therapeutic regimens
Zhai et al. Injectable chitosan-based hydrogel via in situ gelation modulates the inflammatory microenvironment and facilitates minimally invasive repair of peripheral nerve injury
Zair et al. Abdominal hernia repair surgery with the new injectable polymer biomaterials
EP2968402B1 (en) Medical device having a coating comprising accs
AU2013202662B2 (en) Hemostatic compositions and therapeutic regimens
TW202142275A (zh) Ｐｇｃ薄膜其製備方法及其於皮炎修復之應用
KR20010107068A (ko) 유착방지제
Gorst The synthesis, characterisation and biological evaluation of chitin and chitosan materials
HK1173685B (en) Hemostatic compositions and therapeutic regimens
HK1137370B (en) Hemostatic compositions and therapeutic regimens
HK1173685A (en) Hemostatic compositions and therapeutic regimens

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250815

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250815